Jones DR - Search Results

1

Novel targeted therapies for non-small cell lung cancer.

Smith PW, Denlinger CE, Jones DR. Smith PW, et al. Among authors: jones dr. Thorac Surg Clin. 2006 Nov;16(4):353-66. doi: 10.1016/j.thorsurg.2006.09.002. Thorac Surg Clin. 2006. PMID: 17240823 Review.

2

Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.

Jones DR, Broad RM, Madrid LV, Baldwin AS Jr, Mayo MW. Jones DR, et al. Ann Thorac Surg. 2000 Sep;70(3):930-6; discussion 936-7. doi: 10.1016/s0003-4975(00)01635-0. Ann Thorac Surg. 2000. PMID: 11016336

3

Inhibition of nuclear factor kappaB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation.

Jones DR, Broad RM, Comeau LD, Parsons SJ, Mayo MW. Jones DR, et al. J Thorac Cardiovasc Surg. 2002 Feb;123(2):310-7. doi: 10.1067/mtc.2002.118684. J Thorac Cardiovasc Surg. 2002. PMID: 11828291 Free article.

4

Acquired systemic-to-pulmonary arteriovenous malformation secondary to Mycobacterium tuberculosis empyema.

Denlinger CE, Egan TM, Jones DR. Denlinger CE, et al. Among authors: jones dr. Ann Thorac Surg. 2002 Oct;74(4):1229-31. doi: 10.1016/s0003-4975(02)03860-2. Ann Thorac Surg. 2002. PMID: 12400775

5

Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway.

Mayo MW, Denlinger CE, Broad RM, Yeung F, Reilly ET, Shi Y, Jones DR. Mayo MW, et al. Among authors: jones dr. J Biol Chem. 2003 May 23;278(21):18980-9. doi: 10.1074/jbc.M211695200. Epub 2003 Mar 20. J Biol Chem. 2003. PMID: 12649266 Free article.

6

Pulmonary segmentectomy: results and complications.

Jones DR, Stiles BM, Denlinger CE, Antippa P, Daniel TM. Jones DR, et al. Ann Thorac Surg. 2003 Aug;76(2):343-8; discussion 348-9. doi: 10.1016/s0003-4975(03)00437-5. Ann Thorac Surg. 2003. PMID: 12902061

7

Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer.

Denlinger CE, Keller MD, Mayo MW, Broad RM, Jones DR. Denlinger CE, et al. Among authors: jones dr. J Thorac Cardiovasc Surg. 2004 Apr;127(4):1078-86. doi: 10.1016/s0022-5223(03)01321-7. J Thorac Cardiovasc Surg. 2004. PMID: 15052205 Free article.

8

Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.

Rundall BK, Denlinger CE, Jones DR. Rundall BK, et al. Among authors: jones dr. Surgery. 2004 Aug;136(2):416-25. doi: 10.1016/j.surg.2004.05.018. Surgery. 2004. PMID: 15300209

9

Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-kappaB.

Denlinger CE, Rundall BK, Jones DR. Denlinger CE, et al. Among authors: jones dr. Semin Thorac Cardiovasc Surg. 2004 Spring;16(1):28-39. doi: 10.1053/j.semtcvs.2003.12.004. Semin Thorac Cardiovasc Surg. 2004. PMID: 15366685 Review.

10

Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.

Denlinger CE, Rundall BK, Keller MD, Jones DR. Denlinger CE, et al. Among authors: jones dr. Ann Thorac Surg. 2004 Oct;78(4):1207-14; discussion 1207-14. doi: 10.1016/j.athoracsur.2004.04.029. Ann Thorac Surg. 2004. PMID: 15464472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,382 results

Search Page